First Community Trust’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-100
Closed -$1.35K 293
2023
Q2
$1.35K Hold
100
﹤0.01% 287
2023
Q1
$1.39K Hold
100
﹤0.01% 285
2022
Q4
$1K Hold
100
﹤0.01% 300
2022
Q3
$1K Hold
100
﹤0.01% 290
2022
Q2
$1K Hold
100
﹤0.01% 356
2022
Q1
$2K Hold
100
﹤0.01% 354
2021
Q4
$1.92K Buy
+100
New +$2.01K ﹤0.01% 357

Other funds holding HQL

First Community Trust's HQL Position: Q3 2023 in Review

First Community Trust sold out of abrdn Life Sciences Investors (HQL) in Q3 2023, closing a stake of 100 shares — an estimated $1.35K sold.

First Community Trust first reported a position in HQL in Q4 2021 and held it in 7 quarters. The position peaked at $2K in Q1 2022. 80 funds tracked by Wall St. Rank hold HQL as of Q3 2023.

  • First Community Trust reported no remaining abrdn Life Sciences Investors position as of Q3 2023 after selling out during the quarter.
  • First Community Trust sold 100 abrdn Life Sciences Investors shares in Q3 2023, an estimated $1.35K.
  • First Community Trust first reported a position in abrdn Life Sciences Investors in Q4 2021 and held it in 7 quarters.
  • First Community Trust's abrdn Life Sciences Investors position peaked at $2K in Q1 2022.
  • 80 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2023.

Based on First Community Trust's 13F filing for Q3 2023, filed 10 Oct 2023.